We would like to inform you that our research survey will be closing on 15 February. If you haven't completed the survey yet, please do so before the closing date. Your input is valuable for our research and we greatly appreciate your time and effort in participating!

The Luxembourg Healthy Ageing Study aims to characterise the risk factors for developing age-related neurodegenerative diseases, especially Parkinson’s disease.

Neurodegenerative diseases are progressive diseases of the brain, like Parkinson’s or Alzheimer’s disease, that occur with ageing. It is estimated that 8.5 million people worldwide are affected by Parkinson’s disease and 55 million by Alzheimer’s disease or another form of dementia. With the higher life expectancy, this number will increase significantly in the coming years.

We are looking for participants living in Luxembourg and the Greater Region between 50 and 80 years old. With YOUR participation in this online survey, you can actively contribute to the research aims of this international study, which are

  • Early detection of people in Luxembourg and the Greater Region at risk for developing age-related neurodegenerative disease;
  • Discovery of novel risk factors for developing an age-related neurodegenerative disease;
  • Gaining insight into strategies for preventing the development of neurodegenerative diseases.

The Luxembourg Healthy Ageing Study is part of an international effort in which scientists from Luxembourg, Germany, Austria and Spain collaborate to shed light on the risk factors underlying neurodegenerative diseases in Europe.

In Luxembourg, the Healthy Brain Ageing (HeBA) project is organised under the framework of the National Centre of Excellence in Research on Parkinson’s Disease (NCER-PD), in collaboration with the University of Luxembourg and the Luxembourg Institute of Health. The international partners involved in HeBA are the Paracelsus-Elena-Klinik in Kassel, the University Medical Centre in Göttingen (Germany), the Innsbruck Medical University (Austria) and the Hospital Clinic de Barcelona (Spain). This study is financed by the Michael J Fox Foundation..